Aetiological considerations associated with use of psychoactive substance or medication (Q45095): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||
| Property / Canary Token | |||
dki-india-HA40.2 | |||
| Property / Canary Token: dki-india-HA40.2 / rank | |||
Normal rank | |||
Revision as of 12:54, 13 August 2026
This category should be assigned when there is evidence that the direct physiological effects of a psychoactive substance or medication are an important contributing factor to the Sexual Dysfunction or Sexual Pain Disorder. Examples include selective serotonin reuptake inhibitors, histamine-2 receptor antagonists (e.g., cimetidine), alcohol, opioids, and amphetamines. If the diagnostic requirements for a Disorder Due to Substance Use are met, the appropriate Disorder Due to Substance Use diagnosis should also be assigned.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | HA40.2 |
||
| English | Aetiological considerations associated with use of psychoactive substance or medication |
This category should be assigned when there is evidence that the direct physiological effects of a psychoactive substance or medication are an important contributing factor to the Sexual Dysfunction or Sexual Pain Disorder. Examples include selective serotonin reuptake inhibitors, histamine-2 receptor antagonists (e.g., cimetidine), alcohol, opioids, and amphetamines. If the diagnostic requirements for a Disorder Due to Substance Use are met, the appropriate Disorder Due to Substance Use diagnosis should also be assigned. |
Statements
CID11:HA40.2
0 references
dki-india-HA40.2
0 references
